ERS International Congress, Milan 2017


Wednesday, 13.09.2017

Start-End Session Type
08:30 - 10:30 518 In the frontline of the fight against tuberculosis Hot topics
08:30 - 10:30 519 Update on weaning from the ventilator Symposium
08:30 - 10:30 520 Treatment and prevention of COPD exacerbation Session
08:30 - 10:30 521 A novel approach to lung cancer Hot topics
08:30 - 10:30 522 Chemical and biological indoor and outdoor pollution Hot topics
08:30 - 10:30 523 Personalised care for emphysema in COPD Symposium
08:30 - 10:30 524 Paediatric respiratory infections and immunity Oral Presentation
08:30 - 10:30 525 From idiopathic pulmonary fibrosis (IPF) to rare diseases Oral Presentation
08:30 - 10:30 526 Novel imaging findings characterising various lung diseases and their prognoses Oral Presentation
08:30 - 10:30 527 Hospital-acquired infections: from prevention to treatment Oral Presentation
08:30 - 10:30 528 New perspectives from experimental models of pulmonary hypertension Oral Presentation
08:30 - 10:30 529 New trends in pulmonary rehabilitation and chronic care Oral Presentation
08:30 - 10:30 530 Notable abstracts in asthma Oral Presentation
08:30 - 10:30 531 Asthma: mechanisms and treatment Poster Discussion
08:30 - 10:30 532 Assessing functional outcomes in chronic respiratory disease Poster Discussion
08:30 - 10:30 533 CPAP therapy Poster Discussion
08:30 - 10:30 534 The acute patient: the clinical point-of-view Poster Discussion
08:30 - 10:30 535 Monitoring asthma control Poster Discussion
08:30 - 10:30 536 Asthma: clinical and epidemiologic characterisation Poster Discussion
08:30 - 10:00 537 PDW NOT FOR 2017 How to get the job you want Professional development workshop
10:45 - 12:45 539 Controversies in community-acquired pneumonia: a pro and con debate Symposium
10:45 - 12:45 540 Malignant pleural effusion management in 2017: a review of recent RCTs Symposium
10:45 - 12:45 541 From small airways dysfunction to dyspnoea in COPD: from physiology to clinical application Symposium
10:45 - 12:45 542 Innovation in diagnosing and monitoring respiratory disease Symposium
10:45 - 12:45 543 Omics in paediatric asthma and beyond Symposium
10:45 - 12:45 544 Pulmonary emergencies year in review Year in review
10:45 - 12:45 545 Smoking and molecular findings Oral Presentation
10:45 - 12:45 546 Towards new anti-inflammatory and anti-fibrotic agents Oral Presentation
10:45 - 12:45 547 Phenotyping obstructive sleep apnoea Oral Presentation
10:45 - 12:45 548 New immune markers for asthma and COPD Oral Presentation
10:45 - 12:45 549 Treatment of multi-drug-resistant tuberculosis (MDRTB): where are we now? Oral Presentation
10:45 - 12:45 550 Lung cancer: latest basic research on molecular alterations, tumour-immune system-microenvironment interplay and the metabolome Oral Presentation
10:45 - 12:45 551 Innovation in pulmonary rehabilitation and chronic care Oral Presentation
10:45 - 12:45 552 Idiopathic pulmonary fibrosis: from the bench to the bedside Poster Discussion
10:45 - 12:45 553 New insights into pulmonary rehabilitation in patients with chronic lung diseases Poster Discussion
10:45 - 12:45 554 Therapeutic approaches in lung disease Poster Discussion
10:45 - 12:45 555 From the bench: therapeutic approaches in COPD and emphysema Poster Discussion
10:45 - 12:45 556 Gene signatures in bronchial diseases Poster Discussion
10:45 - 12:45 557 What is new in COPD management and prognosis: findings from large studies? Poster Discussion